Statement Revise 2020 Company Q2 30/06/2020 2020 Consolidated Q2 30/06/2020 2019 Reviewed Company Q3 30/09/2019 Unable to reach any conclusion with an emphasis of matters /Others 2019
any conclusion with an emphasis of matters /Others 2019 Reviewed Consolidated Q3 30/09/2019 Unable to reach any conclusion with an emphasis of matters /Others 2019 Reviewed Company Q2 30/06/2019
: Million THB Cash and cash equivalents 50.75 2.91% 82.42 5.23% (31.67) -38.43% Trade Receivables&Other current receivables 248.30 14.24% 231.72 14.72% 16.58 7.16% Inventories 258.17 14.81% 114.52 7.27
opinion with an emphasis of matters 2019 Reviewed Company Q3 30/09/2019 Unable to reach any conclusion with an emphasis of matters 2019 Reviewed Consolidated Q3 30/09/2019 Unable to reach any conclusion
market devaluation of the securities as at March 31, 2020 but it was unrealized loss. Unit : Million THB Cash and cash equivalents 117.94 6.93% 82.42 5.23% 35.52 43.10% Trade Receivables&Other current
conduct a Health Study Report in February 2020 where the conclusion of the report showed that the useful lives of buildings should be less than the current estimates according to the condition of buildings
Reviewed Company Q3 30/09/2019 Unable to reach any conclusion with an emphasis of matters /Others 2019 Reviewed Consolidated Q3 30/09/2019 Unable to reach any conclusion with an emphasis of matters
30/06/2020 Unable to reach any conclusion with an emphasis of matters /Others 2020 Reviewed Consolidated Q2 30/06/2020 Unable to reach any conclusion with an emphasis of matters /Others 2020
Consolidated Year 31/12/2020 2020 Company Q2 30/06/2020 2020 Consolidated Q2 30/06/2020 2019 Reviewed Company Q3 30/09/2019 Unable to reach any conclusion with an emphasis of matters